XENETIC BIOSCIENCES, INC. Operating Leases, Rent Expense
XENETIC BIOSCIENCES, INC. (XBIO) reported Operating Leases, Rent Expense of $128.61 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2017-03-31
- XENETIC BIOSCIENCES, INC. operating leases, rent expense for fiscal 2016 was $128.61K, a 4.65% decline from fiscal 2015.
- XENETIC BIOSCIENCES, INC. operating leases, rent expense for fiscal 2015 was $134.88K, a 21.96% decline from fiscal 2014.
- XENETIC BIOSCIENCES, INC. operating leases, rent expense for fiscal 2014 was $172.82K, a 38.41% decline from fiscal 2013.
- XENETIC BIOSCIENCES, INC. operating leases, rent expense for fiscal 2013 was $280.61K.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2016-12-31 | $128.61K 10-K · filed 2017-03-31 |
| 2015-12-31 | $134.88K 10-K · filed 2017-03-31 |
| 2014-12-31 | $172.82K 10-K · filed 2016-03-30 |
| 2013-12-31 | $280.61K 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |